title: Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer.
abstract: OBJECTIVE
  Concentrations of tumour necrosis factor-alpha (TNF-alpha) were assayed by radioimmunoassay in serum samples collected between 1981 and 1987 from 111 patients with asbestosis who were at a high risk of cancer. Follow up of these patients until 1993 showed that 38 had developed cancer (27 lung, three mesotheliomas, and eight diverse malignancies).
  
  
  RESULTS
  The mean serum concentrations of TNF-alpha given in fmol/100 microliters serum in all the cases with cancer (14.1) and the cases with lung cancer (13.6) were significantly higher (P < 0.05) than the mean concentrations in the exposed controls (10.5). A positive increase was considered to be any value that was > 2 SDs above the mean of the exposed controls. 22% (six of 27) of the cases with lung cancer were positive compared with 4% (three of 73) of the exposed controls, a significant difference (P < 0.001). The serum concentrations of TNF-alpha correlated moderately with cancer (r = 0.3), lung cancer (r = 0.3), and Neu oncoproteins and epidermal growth factor receptor (EGFR) (r = 0.3, 0.5 respectively). Also, there was a significant correlation between development of cancer and severity or progression of asbestosis. There was no correlation between the concentrations of TNF-alpha and severity or progression of asbestosis.
  
  
  CONCLUSIONS
  These results showed high concentrations of TNF-alpha in the patients who had cancer. TNF-alpha may offer an auxiliary method in early diagnosis of cancers related to asbestosis.
authors.affiliation: Center for Nutrition and Toxicology, Karolinska Institute, Huddinge, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Partanen
authors.forename: H
authors.initials: H
authors.lastname: Koskinen
authors.forename: K
authors.initials: K
authors.lastname: Hemminki
mesh_terms: D000328:Adult; D001195:Asbestosis / Q000097:blood* / Q000150:complications / Q000473:pathology; D014408:Biomarkers, Tumor / Q000097:blood*; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D008297:Male; D008654:Mesothelioma / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D014409:Tumor Necrosis Factor-alpha